Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behçet’s disease

Overview of attention for article published in Clinical Ophthalmology, March 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Comparing biologic options for the management of Behcet’s disease-related uveitis

Article in Expert Review of Clinical Immunology (February 2023)

Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study

Article in Frontiers in Medicine (January 2023)

Long-term outcomes of infliximab in patients with Behçet's disease-associated uveitis

Article in International Ophthalmology (September 2022)